Vaccines News
-
Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children
Vaccines | News | 0 Comment | 03 Dec, 2024
American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...Read more
-
Sanofi introduces 'Modulus', world’s first modular manufacturing facility in Singapore
Vaccines | News | 0 Comment | 27 Nov, 2024
Sanofi announced the inauguration of its state-of-theart manufacturing facility, Modulus, in Singapore, on 27 Nov, marki...Read more
-
Korea-Africa partnership for advancing vaccine end-to-end capabilities
Vaccines | News | 0 Comment | 27 Nov, 2024
The Government of the Republic of Kenya and the International Vaccine Institute (IVI) in South Korea, have signed a Memo...Read more
-
Sanofi, A*STAR and NSC collaborate to advance Acne Vaccine R&D in Singapore
Vaccines | News | 0 Comment | 22 Nov, 2024
Sanofi, the Agency for Science, Technology and Research (A*STAR), and the National Skin Centre Singapore (NSC) establish...Read more
-
Vaccines | Analysis | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 25 Nov, 2024
Vaccines are the bedrock of public health, providing preventive solutions against infectious diseases while increasingly...Read more
-
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan
Vaccines | News | 0 Comment | 18 Nov, 2024
Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...Read more
-
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH
Vaccines | News | 2 Comment | 29 Oct, 2024
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...Read more
-
SK bioscience's Quadrivalent Influenza Vaccine SKYCellflu approved in Indonesia
Vaccines | News | 0 Comment | 23 Oct, 2024
SK bioscience, a global innovator in vaccines and biotechnology, announced that Indonesia's Food and Drug Agency, BPOM (...Read more
-
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding
Vaccines | News | 0 Comment | 13 Oct, 2024
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...Read more
-
Vaccines | News | 1 Comment | 10 Oct, 2024
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to...Read more
-
SK bioscience invests $3 M in US-based FinaBio specialising in next-gen conjugate vaccine technology
Vaccines | News | 0 Comment | 08 Oct, 2024
South Korea-based SK bioscience has signed an agreement to acquire a stake in Fina Biosolutions, a promising R&D bio...Read more
-
Cenra Healthcare to promote Moderna’s mRNA respiratory vaccine portfolio in Taiwan
Vaccines | News | 0 Comment | 01 Oct, 2024
Moderna, Inc. and Cenra Healthcare, the sales and marketing arm of Cenra Inc., have entered into a joint agreement regar...Read more
-
Singapore HSA approves Abrysvo Vaccine by Pfizer to combat Respiratory Syncytial Virus (RSV)
Vaccines | News | 0 Comment | 25 Sep, 2024
Singapore Health Sciences Authority (HSA) has approved the Pfizer's bivalent vaccine, Abryvso, for active immu...Read more
-
WHO prequalifies first vaccine against mpox
Vaccines | News | 0 Comment | 16 Sep, 2024
The World Health Organization (WHO) has announced MVA-BN vaccine as the first vaccine against mpox to be added to its pr...Read more
-
Japan approves self-amplifying mRNA COVID-19 vaccine for protection against JN.1 strain
Vaccines | News | 0 Comment | 13 Sep, 2024
Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...Read more
-
GSK announces launch of Herpes Zoster vaccine Shingrix in Malaysia
Vaccines | News | 0 Comment | 13 Sep, 2024
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) has announced the launch of its Herpes Zoster vaccine, Shingrix, ...Read more
-
BIOCHINA 2025: China’s Largest Bio Convention to Host Over 3,000 Biotech Companies
Vaccines | News | 0 Comment | 12 Sep, 2024
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...Read more
-
French firm Osivax grants rights to KM Biologics to develop and market influenza vaccine in Japan
Vaccines | News | 0 Comment | 10 Sep, 2024
Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...Read more
